— Know what they know.
Not Investment Advice
Also trades as: 0M3Q.L (LSE) · $vol 1M · ZOE.DE (XETRA) · $vol 0M

ZTS NYSE

Zoetis Inc.
1W: -2.3% 1M: +9.5% 3M: +0.3% YTD: -37.6% 1Y: -46.2% 3Y: -52.0% 5Y: -60.2%
$78.23
-2.74 (-3.38%)
 
Weekly Expected Move ±3.6%
$75 $78 $81 $84 $87
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 74 · $32.3B mcap · 412M float · 1.34% daily turnover · Short 41% of daily vol
Credit Risk of going bust: lower than 57% of companies Debt: 22.2% of company value Bonds: $301.2M held by 308 funds, 68 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.76 (down 98%), Zoetis Inc. would be worth roughly what it owes.
Total debt $9.24B against a stock market value of $32.33B.
Distance to default 5.81 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.52B (short-term plus half of long-term), stock volatility 40.4%; Altman Z 4.73. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WIDE EDGE
73.0 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 26.3%  ·  5Y Avg: 23.2%
Cost Advantage
75
Intangibles
72
Switching Cost
76
Network Effect
50
Scale ★
90
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ZTS possesses a Wide competitive edge (73.0/100) — durable structural advantages that are difficult for competitors to erode. The primary source of advantage is Efficient Scale. ROIC of 26.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$74
Low
$83
Avg Target
$94
High
Based on 5 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 13Hold: 18Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$83.20
Analysts5
Consensus Change History
DateFieldFromTo
2026-05-29 consensus Buy Hold
2026-05-19 consensus Hold Buy
2026-02-13 consensus Buy Hold
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-20 Jefferies Keith Devas $254 $83 -171 +4.3% $79.59
2026-10-16 Goldman Sachs — Initiated $74 — -5.6% $78.42
2026-08-25 Cantor Fitzgerald — Initiated $94 — +21.8% $77.17
2026-08-20 Stifel Nicolaus Jonathan Block $85 $80 -5 +4.3% $76.68
2026-08-07 Morgan Stanley — $99 $85 -14 +12.9% $75.30
2026-07-27 UBS — $99 $85 -14 +11.1% $76.52
2026-07-22 Morgan Stanley — $115 $99 -16 +31.1% $75.50
2026-07-06 HSBC — $140 $95 -45 +27.3% $74.63
2026-07-01 Barclays — $136 $85 -51 +18.2% $71.91
2026-06-26 Stifel Nicolaus — $95 $85 -10 +9.2% $77.82
2026-05-22 Stifel Nicolaus — $105 $95 -10 +18.7% $80.06
2026-05-15 Morgan Stanley Erin Wright $160 $115 -45 +51.2% $76.06
2026-05-08 UBS — $130 $99 -31 +18.9% $83.27
2026-05-08 Stifel Nicolaus — $140 $105 -35 +20.3% $87.31
2026-04-28 UBS — $136 $130 -6 +11.4% $116.71
2026-02-26 BTIG Mark Massaro Initiated $160 — +24.1% $128.95
2026-01-29 UBS — $158 $136 -22 +10.8% $122.75
2026-01-22 Piper Sandler David Westenberg $215 $135 -80 +7.9% $125.08
2025-12-18 Morgan Stanley — $243 $160 -83 +28.5% $124.54
2025-12-10 HSBC — Initiated $140 — +21.0% $115.75
2025-12-08 Barclays — $242 $136 -106 +15.1% $118.16
2025-11-04 Stifel Nicolaus — $160 $140 -20 +11.6% $125.50
2025-10-20 UBS — $170 $158 -12 +9.0% $144.90
2025-08-11 Piper Sandler David Westenberg $195 $215 +20 +44.4% $148.86
2025-06-17 Stifel Nicolaus Jonathan Block $165 $160 -5 -1.0% $161.67
2025-05-07 UBS Andrea Alfonso Initiated $170 — +13.4% $149.87
2025-04-14 Stifel Nicolaus Jonathan Block $200 $165 -35 +9.4% $150.83
2025-02-04 Morgan Stanley Erin Wright $248 $243 -5 +41.1% $172.24
2024-08-07 Barclays Balaji Prasad Initiated $242 — +30.6% $185.29
2024-08-05 Stifel Nicolaus Jonathan Block $195 $200 +5 +13.4% $176.31
2024-04-16 Piper Sandler David Westenberg Initiated $195 — +30.2% $149.77
2024-04-02 Stifel Nicolaus Jonathan Block Initiated $195 — +16.8% $167.02
2022-11-15 Morgan Stanley — Initiated $248 — +65.1% $150.25
2022-02-20 Jefferies David Steinberg Initiated $254 — +32.8% $191.32
2021-08-24 Argus Research Jasper Hellweg Initiated $225 — +10.4% $203.86
2021-08-08 Credit Suisse Katie Tryhane Initiated $230 — +15.5% $199.16

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 27, 2026
DCF
5
ROE
5
ROA
5
D/E
1
P/E
3
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ZTS receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 B+ A-
2026-08-14 A- B+
2026-08-11 A A-
2026-08-07 B+ A
2026-07-30 A- B+
2026-07-27 B+ A-
2026-05-20 A- B+
2026-05-12 A A-
2026-05-08 B+ A
2026-01-16 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 66 Grade B
Profitability
98
Balance Sheet
56
Earnings Quality
76
Growth
47
Value
71
Momentum
66
Safety
100
Cash Flow
65
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ZTS scores highest in Safety (100/100) and lowest in Growth (47/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.61
Safe Zone
Piotroski F-Score
6/9
✓ ✓ ✗ ✓ ✗ ✓ ✓ ✓ ✗
Beneish M-Score
-2.55
Unlikely Manipulator
Ohlson O-Score
-7.32
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
AA
Score: 85.3/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.10x
Accruals: -1.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ZTS scores 4.61, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ZTS scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ZTS's score of -2.55 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ZTS's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ZTS receives an estimated rating of AA (score: 85.3/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ZTS's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
12.87x
PEG
2.88x
P/S
3.40x
P/B
10.38x
P/FCF
12.69x
P/OCF
10.40x
EV/EBITDA
9.41x
EV/Revenue
3.95x
EV/EBIT
10.71x
EV/FCF
15.88x
Earnings Yield
8.72%
FCF Yield
7.88%
Shareholder Yield
15.10%
Graham Number
$32.59
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 12.9x earnings, ZTS trades at a reasonable valuation. An earnings yield of 8.7% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $32.59 per share, 140% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.800
NI / EBT
×
Interest Burden
0.932
EBT / EBIT
×
EBIT Margin
0.369
EBIT / Rev
×
Asset Turnover
0.644
Rev / Assets
×
Equity Multiplier
3.638
Assets / Equity
=
ROE
64.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ZTS's ROE of 64.4% is driven by financial leverage (equity multiplier: 3.64x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
9.42%
Fair P/E
27.34x
Intrinsic Value
$171.22
Price/Value
0.42x
Margin of Safety
58.03%
Premium
-58.03%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ZTS's realized 9.4% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ZTS trades at a -58% premium to its adjusted intrinsic value of $171.22, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 27.3x compares to the current market P/E of 12.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$78.20
Median 1Y
$70.46
5th Pctile
$43.64
95th Pctile
$113.84
Ann. Volatility
30.3%
Analyst Target
$83.20
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Kristin C. Peck
Chief Executive Officer
$1,300,000 $9,562,347 $17,206,760
Wetteny Joseph (“EVP”)
ve Vice President (“EVP”) and Chief Financial Officer
$750,000 $2,390,440 $5,089,461
Heidi C. Chen
Former EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics
$346,808 $1,060,885 $3,621,101
Jamie Brannan EVP
and Chief Commercial Officer
$659,423 $910,910 $3,024,611
Robert J. Polzer
EVP and President of Research and Development
$660,000 $1,087,447 $2,973,038
Wafaa Mamilli EVP,
er EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health
$650,000 $1,034,593 $2,784,279
Roxanne Lagano EVP,
General Counsel and Corporate Secretary
$620,833 $937,202 $2,615,155

CEO Pay Ratio

105:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $17,206,760
Avg Employee Cost (SGA/emp): $164,000
Employees: 14,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
14,500
+5.1% YoY
Revenue / Employee
$652,897
Rev: $9,467,000,000
Profit / Employee
$184,345
NI: $2,673,000,000
SGA / Employee
$164,000
Avg labor cost proxy
R&D / Employee
$48,138
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 47.9% 49.0% 47.4% 46.8% 44.3% 47.3% 45.3% 48.1% 46.8% 49.9% 50.1% 48.9% 47.1% 50.9% 51.8% 52.5% 49.9% 66.0% 67.0% 64.4% 64.39%
ROA 14.5% 14.8% 15.0% 15.0% 15.1% 14.7% 15.0% 16.1% 16.4% 16.0% 17.0% 16.8% 17.1% 17.4% 17.7% 18.2% 18.0% 18.0% 18.1% 17.7% 17.70%
ROIC 27.5% 29.4% 28.1% 26.7% 25.5% 26.1% 24.7% 24.1% 24.0% 25.2% 25.5% 25.7% 25.9% 28.4% 28.1% 26.9% 26.6% 27.2% 27.1% 26.3% 26.28%
ROCE 21.6% 22.5% 25.5% 26.0% 25.9% 24.6% 24.3% 25.7% 25.1% 25.7% 26.0% 25.4% 26.0% 31.2% 32.1% 32.0% 26.7% 27.1% 27.0% 27.0% 26.97%
Gross Margin 68.5% 67.5% 69.3% 67.7% 67.8% 66.3% 68.8% 70.5% 68.6% 65.4% 68.9% 70.2% 69.2% 68.0% 70.5% 72.3% 70.2% 68.9% 71.7% 72.7% 72.73%
Operating Margin 36.6% 30.3% 39.7% 35.4% 36.1% 33.8% 36.4% 38.3% 37.1% 32.0% 36.6% 38.4% 38.5% 33.0% 38.1% 40.2% 39.0% 34.6% 36.3% 38.0% 37.97%
Net Margin 27.7% 21.0% 30.0% 25.8% 26.4% 22.6% 27.6% 30.8% 27.7% 23.7% 27.4% 26.4% 28.6% 25.1% 28.4% 29.2% 30.0% 25.3% 26.6% 28.0% 28.00%
EBITDA Margin 41.6% 34.6% 45.2% 41.1% 41.9% 38.1% 44.2% 48.4% 42.0% 37.7% 42.7% 41.1% 44.2% 39.3% 44.5% 44.0% 44.5% 39.3% 41.5% 42.4% 42.38%
FCF Margin 23.6% 22.3% 20.4% 17.9% 15.8% 16.4% 18.0% 15.6% 17.8% 19.0% 20.0% 23.6% 25.2% 24.8% 24.6% 23.6% 23.8% 24.1% 22.5% 24.9% 24.86%
OCF Margin 29.6% 28.5% 26.9% 24.7% 23.1% 23.7% 26.6% 24.3% 26.2% 27.5% 27.5% 30.5% 32.2% 31.9% 31.7% 31.2% 31.0% 30.7% 28.6% 30.3% 30.34%
ROE 3Y Avg snapshot only 60.93%
ROE 5Y Avg snapshot only 55.25%
ROA 3Y Avg snapshot only 17.31%
ROIC 3Y Avg snapshot only 21.53%
ROIC Economic snapshot only 23.08%
Cash ROA snapshot only 19.15%
Cash ROIC snapshot only 26.96%
CROIC snapshot only 22.09%
NOPAT Margin snapshot only 29.58%
Pretax Margin snapshot only 34.38%
R&D / Revenue snapshot only 7.59%
SGA / Revenue snapshot only 24.99%
SBC / Revenue snapshot only 1.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 44.79 54.76 41.52 37.40 32.52 31.33 36.24 35.03 34.32 37.85 31.80 33.12 35.90 29.18 29.00 26.42 24.38 20.65 18.89 11.47 12.867
P/S Ratio 11.66 14.35 10.91 9.78 8.39 8.20 9.27 9.43 9.35 10.39 8.70 8.71 9.53 7.84 7.86 7.35 6.88 5.83 5.25 3.15 3.397
P/B Ratio 18.97 24.55 18.48 17.07 14.41 15.04 16.70 16.76 15.41 17.76 15.03 15.63 16.67 15.21 15.69 13.86 11.97 16.57 15.44 9.53 10.378
P/FCF 49.35 64.26 53.56 54.70 53.05 49.95 51.47 60.34 52.45 54.74 43.44 36.92 37.79 31.56 32.01 31.10 28.85 24.17 23.38 12.69 12.686
P/OCF 39.42 50.41 40.56 39.54 36.33 34.64 34.87 38.78 35.62 37.71 31.69 28.57 29.62 24.56 24.79 23.56 22.16 19.00 18.37 10.40 10.397
EV/EBITDA 29.92 36.20 27.91 25.32 21.92 21.07 23.81 23.20 22.98 25.39 21.67 22.73 24.31 19.96 19.88 18.41 17.23 15.29 14.20 9.41 9.411
EV/Revenue 12.11 14.77 11.36 10.29 8.92 8.76 9.84 10.04 9.94 10.94 9.25 9.29 10.08 8.35 8.40 7.92 7.43 6.59 6.02 3.95 3.949
EV/EBIT 34.90 42.15 32.49 29.47 25.55 24.46 27.72 26.78 26.52 29.30 25.00 26.37 28.00 22.90 22.72 20.93 19.60 17.36 16.15 10.71 10.706
EV/FCF 51.28 66.14 55.80 57.56 56.40 53.36 54.65 64.25 55.79 57.65 46.19 39.38 39.98 33.63 34.21 33.51 31.17 27.32 26.79 15.88 15.882
Earnings Yield 2.2% 1.8% 2.4% 2.7% 3.1% 3.2% 2.8% 2.9% 2.9% 2.6% 3.1% 3.0% 2.8% 3.4% 3.4% 3.8% 4.1% 4.8% 5.3% 8.7% 8.72%
FCF Yield 2.0% 1.6% 1.9% 1.8% 1.9% 2.0% 1.9% 1.7% 1.9% 1.8% 2.3% 2.7% 2.6% 3.2% 3.1% 3.2% 3.5% 4.1% 4.3% 7.9% 7.88%
PEG Ratio snapshot only 2.880
EV/OCF snapshot only 13.016
EV/Gross Profit snapshot only 5.571
Acquirers Multiple snapshot only 10.673
Shareholder Yield snapshot only 15.10%
Graham Number snapshot only $32.59
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 4.54 3.86 2.25 2.18 2.27 2.37 3.27 3.50 3.87 3.36 3.33 3.45 3.69 1.75 1.74 1.76 3.64 3.03 3.15 3.08 3.084
Quick Ratio 3.27 2.79 1.58 1.46 1.48 1.63 1.94 1.97 2.16 2.00 1.94 2.09 2.27 1.08 1.04 1.04 2.28 1.94 1.91 1.84 1.835
Debt/Equity 1.44 1.48 1.45 1.47 1.45 1.84 1.50 1.46 1.33 1.35 1.34 1.36 1.29 1.41 1.45 1.36 1.35 2.85 2.86 2.93 2.935
Net Debt/Equity 0.74 0.72 0.77 0.89 0.91 1.02 1.03 1.09 0.98 0.94 0.95 1.04 0.96 1.00 1.08 1.08 0.96 2.16 2.26 2.40 2.402
Debt/Assets 0.49 0.49 0.49 0.49 0.49 0.54 0.49 0.49 0.48 0.47 0.47 0.48 0.47 0.47 0.48 0.47 0.48 0.61 0.61 0.61 0.613
Debt/EBITDA 2.19 2.13 2.10 2.07 2.07 2.41 2.01 1.90 1.86 1.84 1.82 1.85 1.78 1.74 1.72 1.68 1.80 2.33 2.29 2.31 2.314
Net Debt/EBITDA 1.13 1.03 1.12 1.26 1.30 1.34 1.39 1.41 1.38 1.28 1.29 1.42 1.33 1.23 1.28 1.33 1.28 1.76 1.81 1.89 1.894
Interest Coverage 10.97 11.54 11.90 12.19 12.32 12.21 11.55 12.09 12.03 12.60 13.09 12.72 13.45 13.95 14.37 15.18 15.03 15.09 14.70 14.39 14.385
Equity Multiplier 2.93 3.06 2.98 3.01 2.93 3.39 3.06 2.97 2.78 2.86 2.84 2.85 2.74 2.98 3.03 2.91 2.81 4.64 4.69 4.79 4.789
Cash Ratio snapshot only 0.813
Debt Service Coverage snapshot only 16.365
Cash to Debt snapshot only 0.181
FCF to Debt snapshot only 0.256
Defensive Interval snapshot only 367.6 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.56 0.57 0.57 0.57 0.58 0.56 0.59 0.60 0.60 0.58 0.62 0.64 0.64 0.65 0.65 0.66 0.64 0.64 0.65 0.64 0.644
Inventory Turnover 1.41 1.39 1.32 1.27 1.22 1.22 1.13 1.06 1.04 1.10 1.06 1.10 1.12 1.17 1.13 1.15 1.14 1.18 1.13 1.11 1.106
Receivables Turnover 7.04 7.25 6.72 6.50 6.84 6.88 6.72 6.29 6.84 6.78 7.05 6.59 6.86 7.07 7.00 6.42 6.37 6.52 6.63 6.12 6.118
Payables Turnover 6.63 5.52 6.64 6.35 6.73 6.19 6.34 5.82 6.92 6.64 6.67 6.39 7.28 6.78 6.87 6.06 6.86 6.07 6.00 5.78 5.775
DSO 52 50 54 56 53 53 54 58 53 54 52 55 53 52 52 57 57 56 55 60 59.7 days
DIO 259 263 276 288 298 299 322 344 350 331 344 333 327 311 323 317 319 309 323 330 330.0 days
DPO 55 66 55 57 54 59 58 63 53 55 55 57 50 54 53 60 53 60 61 63 63.2 days
Cash Conversion Cycle 256 247 275 287 297 293 319 340 350 329 341 331 330 309 322 314 323 305 317 326 326.5 days
Fixed Asset Turnover snapshot only 2.361
Operating Cycle snapshot only 389.7 days
Cash Velocity snapshot only 5.678
Capital Intensity snapshot only 1.584
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 16.4% 16.5% 12.5% 7.9% 5.1% 3.9% 2.6% 2.8% 4.5% 5.7% 7.9% 8.4% 9.3% 8.3% 6.3% 5.3% 2.7% 2.3% 2.4% 1.4% 1.41%
Net Income 19.2% 24.4% 16.9% 9.5% 4.3% 3.8% -0.1% 5.9% 10.3% 10.9% 15.5% 5.9% 6.6% 6.1% 5.3% 11.4% 9.1% 7.5% 5.0% 0.2% 0.15%
EPS 19.7% 25.0% 17.8% 10.8% 5.9% 5.7% 1.9% 7.9% 12.1% 12.5% 16.9% 7.5% 8.4% 8.2% 7.9% 14.1% 11.6% 10.6% 11.3% 6.8% 6.82%
FCF 18.7% 3.8% -4.5% -16.0% -29.6% -23.6% -9.3% -10.1% 17.8% 22.2% 20.0% 63.7% 54.7% 41.8% 30.3% 5.5% -2.9% -0.7% -6.4% 6.6% 6.62%
EBITDA 14.1% 18.1% 11.7% 7.3% 5.7% 5.9% 4.1% 9.5% 11.1% 9.6% 11.5% 2.4% 4.8% 5.2% 5.2% 10.8% 6.7% 5.3% 2.7% -1.1% -1.11%
Op. Income 20.6% 23.5% 14.2% 6.9% 4.2% 4.5% 1.1% 4.8% 7.6% 4.8% 9.6% 8.0% 9.4% 10.5% 9.4% 9.5% 6.0% 6.0% 4.0% 0.0% 0.03%
OCF Growth snapshot only -1.43%
Asset Growth snapshot only 4.13%
Equity Growth snapshot only -36.75%
Debt Growth snapshot only 36.03%
Shares Change snapshot only -6.24%
Dividend Growth snapshot only 13.15%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 10.0% 10.1% 10.1% 9.8% 9.2% 8.9% 8.5% 9.1% 8.6% 8.6% 7.6% 6.3% 6.3% 6.0% 5.6% 5.5% 5.5% 5.4% 5.5% 5.0% 5.00%
Revenue 5Y 9.3% 9.7% 9.7% 9.8% 9.3% 8.8% 8.3% 8.0% 7.9% 8.0% 8.1% 8.1% 8.3% 8.1% 7.9% 8.2% 7.5% 7.2% 6.3% 5.1% 5.13%
EPS 3Y 20.2% 13.3% 15.0% 15.8% 13.2% 13.2% 9.8% 12.2% 12.4% 14.1% 12.0% 8.7% 8.8% 8.8% 8.7% 9.8% 10.7% 10.4% 12.0% 9.4% 9.42%
EPS 5Y 24.6% 21.0% 20.4% 20.1% 18.3% 20.8% 17.4% 15.9% 15.6% 11.6% 12.6% 12.5% 12.0% 12.0% 10.8% 11.6% 11.5% 12.2% 11.0% 9.4% 9.37%
Net Income 3Y 19.4% 12.6% 14.3% 15.0% 12.3% 12.1% 8.7% 11.0% 11.1% 12.7% 10.5% 7.1% 7.0% 6.9% 6.7% 7.7% 8.6% 8.1% 8.5% 5.7% 5.74%
Net Income 5Y 23.5% 19.9% 19.4% 18.9% 17.1% 19.6% 16.2% 14.7% 14.4% 10.4% 11.5% 11.3% 10.7% 10.6% 9.3% 10.1% 9.8% 10.3% 8.3% 6.5% 6.50%
EBITDA 3Y 12.4% 12.8% 13.0% 12.4% 10.3% 11.0% 9.0% 10.7% 10.3% 11.1% 9.1% 6.4% 7.2% 6.9% 6.9% 7.5% 7.5% 6.7% 6.4% 3.9% 3.92%
EBITDA 5Y 17.6% 15.5% 15.2% 14.5% 13.5% 11.6% 10.6% 10.8% 10.8% 10.7% 10.9% 9.7% 9.3% 9.5% 8.7% 9.0% 8.4% 8.7% 7.0% 5.7% 5.68%
Gross Profit 3Y 10.7% 11.8% 12.5% 11.9% 11.0% 10.0% 8.8% 9.7% 9.3% 9.4% 8.3% 6.9% 6.8% 6.4% 6.1% 6.4% 6.6% 6.8% 7.1% 6.3% 6.26%
Gross Profit 5Y 10.2% 10.8% 11.2% 11.4% 10.9% 9.7% 8.9% 8.7% 8.6% 9.0% 9.5% 9.3% 9.5% 9.2% 8.7% 9.0% 8.5% 8.4% 7.4% 6.2% 6.23%
Op. Income 3Y 11.1% 13.6% 14.8% 13.9% 13.2% 13.2% 10.4% 11.3% 10.6% 10.6% 8.1% 6.6% 7.0% 6.6% 6.6% 7.4% 7.7% 7.1% 7.6% 5.8% 5.78%
Op. Income 5Y 15.8% 14.9% 14.8% 14.4% 13.0% 11.2% 9.5% 9.2% 9.0% 9.9% 10.9% 10.9% 11.3% 10.9% 10.1% 10.3% 9.4% 9.7% 7.5% 5.8% 5.80%
FCF 3Y 5.5% 6.1% 3.7% -0.8% -2.5% -0.2% 3.3% -4.1% -0.5% -1.0% 1.3% 7.3% 8.7% 9.8% 12.4% 15.8% 20.9% 19.9% 13.6% 22.6% 22.57%
FCF 5Y 30.9% 28.4% 23.1% 18.4% 9.0% 3.4% 1.1% -2.3% -0.5% 2.2% 3.9% 7.5% 11.1% 11.5% 11.5% 8.8% 8.1% 6.4% 4.9% 6.8% 6.81%
OCF 3Y 7.5% 7.3% 5.8% 2.4% 1.0% 2.1% 5.9% 1.1% 3.4% 3.4% 4.2% 7.9% 9.4% 10.1% 11.5% 14.0% 16.4% 14.9% 8.1% 13.0% 13.03%
OCF 5Y 26.1% 25.4% 22.1% 19.1% 12.6% 7.3% 5.9% 3.3% 3.9% 5.6% 6.0% 8.1% 10.4% 10.5% 10.2% 8.7% 7.9% 6.4% 5.1% 6.0% 5.96%
Assets 3Y 9.4% 8.9% 8.4% 7.8% 6.7% 8.9% 6.1% 1.7% 0.9% 1.6% 1.3% 0.2% 1.6% 0.8% 0.6% 1.7% 3.5% 1.2% 3.3% 3.1% 3.12%
Assets 5Y 12.2% 12.7% 12.6% 12.0% 8.0% 11.7% 9.6% 9.8% 6.2% 5.8% 5.7% 5.2% 5.0% 4.3% 4.1% 2.1% 2.0% 2.6% 1.9% 1.4% 1.39%
Equity 3Y 30.2% 27.6% 26.2% 23.8% 20.3% 17.6% 17.7% 15.8% 12.1% 9.9% 7.3% 4.5% 3.8% 1.6% -0.0% 2.8% 5.0% -8.9% -10.4% -12.0% -12.04%
Book Value 3Y 31.1% 28.4% 27.0% 24.8% 21.4% 18.7% 18.9% 17.0% 13.5% 11.3% 8.8% 6.1% 5.5% 3.4% 1.9% 4.8% 7.0% -7.0% -7.5% -9.0% -8.97%
Dividend 3Y 8.2% 8.3% 8.7% 9.1% 9.4% 9.9% 8.5% 7.4% 6.4% 5.6% 5.7% 5.9% 6.1% 6.2% 6.3% 6.2% 6.1% 6.4% 6.4% 5.5% 5.54%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.95 0.96 0.98 0.97 0.98 0.97 0.98 0.96 0.97 0.97 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.99 0.97 0.974
Earnings Stability 1.00 0.94 0.98 1.00 0.99 0.93 0.94 0.99 0.98 0.96 0.97 0.97 0.98 0.97 0.97 0.98 0.98 0.97 0.96 0.97 0.969
Margin Stability 0.98 0.98 0.97 0.97 0.97 0.98 0.98 0.99 0.99 0.98 0.97 0.98 0.98 0.98 0.99 0.99 0.98 0.98 0.98 0.98 0.979
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.92 0.90 0.93 0.96 0.98 0.98 1.00 0.98 0.96 0.96 0.94 0.98 0.97 0.98 0.98 0.95 0.96 0.97 0.98 1.00 0.999
Earnings Smoothness 0.82 0.78 0.84 0.91 0.96 0.96 1.00 0.94 0.90 0.90 0.86 0.94 0.94 0.94 0.95 0.89 0.91 0.93 0.95 1.00 0.998
ROE Trend -0.08 -0.05 -0.06 -0.03 0.00 0.04 0.02 0.03 0.02 0.00 0.02 0.00 0.02 0.05 0.07 0.05 0.03 0.31 0.31 0.33 0.333
Gross Margin Trend 0.02 0.02 0.01 0.01 0.01 0.00 -0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.017
FCF Margin Trend 0.01 -0.01 -0.02 -0.05 -0.08 -0.07 -0.04 -0.05 -0.02 -0.00 0.01 0.07 0.08 0.07 0.06 0.04 0.02 0.02 0.00 0.01 0.012
Sustainable Growth Rate 37.0% 37.6% 35.8% 34.6% 31.9% 33.6% 31.5% 33.9% 33.0% 35.1% 35.1% 33.4% 32.3% 34.8% 35.1% 35.7% 33.6% 44.0% 44.5% 42.5% 42.51%
Internal Growth Rate 12.6% 12.8% 12.8% 12.5% 12.2% 11.6% 11.6% 12.8% 13.1% 12.8% 13.5% 13.0% 13.3% 13.5% 13.6% 14.1% 13.8% 13.7% 13.6% 13.2% 13.23%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.14 1.09 1.02 0.95 0.90 0.90 1.04 0.90 0.96 1.00 1.00 1.16 1.21 1.19 1.17 1.12 1.10 1.09 1.03 1.10 1.104
FCF/OCF 0.80 0.78 0.76 0.72 0.68 0.69 0.68 0.64 0.68 0.69 0.73 0.77 0.78 0.78 0.77 0.76 0.77 0.79 0.79 0.82 0.820
FCF/Net Income snapshot only 0.904
OCF/EBITDA snapshot only 0.723
CapEx/Revenue 5.9% 6.1% 6.5% 6.9% 7.3% 7.3% 8.6% 8.7% 8.4% 8.6% 7.4% 6.9% 7.0% 7.1% 7.2% 7.6% 7.2% 6.6% 6.1% 5.5% 5.47%
CapEx/Depreciation snapshot only 1.079
Accruals Ratio -0.02 -0.01 -0.00 0.01 0.02 0.01 -0.01 0.02 0.01 -0.00 -0.00 -0.03 -0.04 -0.03 -0.03 -0.02 -0.02 -0.02 -0.01 -0.02 -0.018
Sloan Accruals snapshot only 0.085
Cash Flow Adequacy snapshot only 2.048
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.5% 0.4% 0.6% 0.7% 0.9% 0.9% 0.8% 0.8% 0.9% 0.8% 0.9% 1.0% 0.9% 1.1% 1.1% 1.2% 1.3% 1.6% 1.8% 3.0% 2.67%
Dividend/Share $0.95 $1.00 $1.07 $1.15 $1.23 $1.31 $1.36 $1.41 $1.45 $1.50 $1.56 $1.62 $1.68 $1.74 $1.81 $1.88 $1.95 $2.03 $2.10 $2.13 $2.09
Payout Ratio 22.8% 23.3% 24.6% 26.0% 27.9% 28.9% 30.5% 29.4% 29.4% 29.5% 29.9% 31.6% 31.4% 31.6% 32.2% 32.1% 32.6% 33.3% 33.6% 34.0% 33.98%
FCF Payout Ratio 25.1% 27.3% 31.7% 38.0% 45.5% 46.1% 43.3% 50.7% 45.0% 42.7% 40.9% 35.2% 33.1% 34.2% 35.6% 37.8% 38.5% 38.9% 41.6% 37.6% 37.57%
Total Payout Ratio 37.7% 59.7% 69.1% 83.8% 95.0% 1.0% 1.0% 92.2% 84.8% 76.1% 78.0% 89.5% 94.8% 1.1% 1.1% 99.7% 97.7% 1.5% 1.6% 1.7% 1.73%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.25 0.25 0.27 0.28 0.29 0.30 0.25 0.21 0.17 0.14 0.14 0.15 0.15 0.15 0.15 0.14 0.14 0.15 0.11 0.09 0.090
Buyback Yield 0.3% 0.7% 1.1% 1.5% 2.1% 2.4% 2.0% 1.8% 1.6% 1.2% 1.5% 1.7% 1.8% 2.6% 2.7% 2.6% 2.7% 5.9% 6.8% 12.1% 12.14%
Net Buyback Yield 0.3% 0.7% 1.1% 1.5% 2.1% 2.4% 2.0% 1.8% 1.6% 1.2% 1.5% 1.7% 1.8% 2.6% 2.7% 2.6% 2.7% 5.9% 6.8% 12.1% 12.14%
Total Shareholder Return 0.8% 1.1% 1.7% 2.2% 2.9% 3.3% 2.9% 2.6% 2.5% 2.0% 2.5% 2.7% 2.6% 3.6% 3.8% 3.8% 4.0% 7.5% 8.6% 15.1% 15.10%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.83 0.82 0.82 0.82 0.80 0.80 0.79 0.78 0.79 0.80 0.80 0.81 0.80 0.79 0.79 0.79 0.80 0.80 0.80 0.80 0.800
Interest Burden (EBT/EBIT) 0.91 0.91 0.92 0.92 0.92 0.92 0.91 0.92 0.92 0.92 0.92 0.92 0.93 0.93 0.93 0.93 0.94 0.94 0.93 0.93 0.932
EBIT Margin 0.35 0.35 0.35 0.35 0.35 0.36 0.36 0.37 0.37 0.37 0.37 0.35 0.36 0.36 0.37 0.38 0.38 0.38 0.37 0.37 0.369
Asset Turnover 0.56 0.57 0.57 0.57 0.58 0.56 0.59 0.60 0.60 0.58 0.62 0.64 0.64 0.65 0.65 0.66 0.64 0.64 0.65 0.64 0.644
Equity Multiplier 3.31 3.31 3.16 3.12 2.93 3.22 3.02 2.99 2.85 3.11 2.94 2.91 2.76 2.92 2.93 2.88 2.78 3.67 3.71 3.64 3.638
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $4.16 $4.28 $4.37 $4.43 $4.41 $4.53 $4.46 $4.78 $4.94 $5.09 $5.21 $5.14 $5.36 $5.51 $5.62 $5.86 $5.98 $6.09 $6.26 $6.26 $6.26
Book Value/Share $9.82 $9.55 $9.82 $9.71 $9.94 $9.44 $9.67 $9.99 $11.01 $10.86 $11.02 $10.89 $11.54 $10.57 $10.39 $11.17 $12.18 $7.59 $7.65 $7.54 $7.54
Tangible Book/Share $0.85 $0.81 $1.15 $1.00 $1.39 $0.60 $0.95 $1.42 $1.99 $1.96 $2.19 $2.20 $2.88 $2.04 $1.91 $2.57 $3.60 $-0.99 $-1.19 $-1.30 $-1.30
Revenue/Share $15.99 $16.35 $16.64 $16.96 $17.07 $17.31 $17.42 $17.76 $18.14 $18.57 $19.04 $19.55 $20.18 $20.52 $20.73 $21.07 $21.20 $21.58 $22.51 $22.78 $22.79
FCF/Share $3.78 $3.65 $3.39 $3.03 $2.70 $2.84 $3.14 $2.78 $3.23 $3.52 $3.81 $4.61 $5.09 $5.09 $5.09 $4.98 $5.05 $5.21 $5.06 $5.66 $5.67
OCF/Share $4.73 $4.65 $4.48 $4.19 $3.94 $4.10 $4.63 $4.32 $4.76 $5.11 $5.23 $5.96 $6.49 $6.55 $6.57 $6.57 $6.58 $6.62 $6.43 $6.91 $6.91
Cash/Share $6.87 $7.32 $6.61 $5.62 $5.34 $7.66 $4.53 $3.70 $3.79 $4.43 $4.30 $3.45 $3.77 $4.40 $3.84 $3.22 $4.70 $5.27 $4.59 $4.01 $4.01
EBITDA/Share $6.47 $6.67 $6.78 $6.89 $6.95 $7.19 $7.20 $7.69 $7.85 $8.00 $8.13 $7.99 $8.37 $8.58 $8.76 $9.06 $9.14 $9.30 $9.54 $9.56 $9.56
Debt/Share $14.18 $14.18 $14.21 $14.28 $14.39 $17.33 $14.51 $14.57 $14.62 $14.68 $14.76 $14.79 $14.90 $14.95 $15.07 $15.24 $16.41 $21.64 $21.87 $22.12 $22.12
Net Debt/Share $7.30 $6.86 $7.60 $8.67 $9.05 $9.67 $9.98 $10.87 $10.82 $10.25 $10.46 $11.34 $11.12 $10.55 $11.23 $12.02 $11.71 $16.37 $17.28 $18.10 $18.10
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 4.612
Altman Z-Prime snapshot only 9.244
Piotroski F-Score 9 9 8 6 5 5 7 7 8 8 9 7 8 7 7 8 6 7 7 6 6
Beneish M-Score -2.49 -2.49 -2.46 -2.36 -2.39 -2.31 -2.54 -2.41 -2.38 -2.40 -2.39 -2.54 -2.54 -2.64 -2.58 -2.49 -2.48 -2.36 -2.42 -2.55 -2.547
Ohlson O-Score snapshot only -7.325
Net-Net WC snapshot only $-13.34
EVA snapshot only $1744078239.61
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA
Credit Score 83.95 84.39 82.67 83.90 83.26 84.38 85.54 86.53 87.61 87.46 86.79 89.24 88.54 84.87 84.66 85.79 89.29 86.18 84.83 85.32 85.325
Credit Grade snapshot only 3
Credit Trend snapshot only -0.464
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 81

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms